PROCEPT BioRobotics (PRCT) Income from Continuing Operations (2020 - 2026)
PROCEPT BioRobotics (PRCT) posted quarterly Income from Continuing Operations of 31638000.0 for Q1 2026, down 27.9% year-over-year from 43879188.5 in Q1 2025, and up 0.73% quarter-over-quarter from 31872000.0 in Q4 2025.
PROCEPT BioRobotics (PRCT) Income from Continuing Operations (2020 - 2026) Analysis & Trends
PROCEPT BioRobotics (PRCT) has reported Income from Continuing Operations for 7 consecutive years, with 31638000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 27.9% year-over-year to 31638000.0; the TTM figure through Mar 2026 stood at 185080000.0 (down 64.85% YoY), while the FY2025 annual figure was 95572000.0, down 4.55% from the prior year.
- Income from Continuing Operations climbed to 31638000.0 in Q1 2026 per PRCT's latest filing, from 31872000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 19316000.0 in Q2 2022 and bottomed at 77956000.0 in Q1 2023.
- Historically, Income from Continuing Operations has averaged 36794588.24 across 5 years, with a median of 31872000.0 in 2025.
- Annual changes were most pronounced in 2023 — Income from Continuing Operations plunged 296.97% — and 2024, when it soared 46.71%.
- PROCEPT BioRobotics' Income from Continuing Operations stood at 23972000.0 in 2022, then tumbled by 33.97% to 32115000.0 in 2023, then surged by 35.08% to 20848000.0 in 2024, then plunged by 52.88% to 31872000.0 in 2025, then gained by 0.73% to 31638000.0 in 2026.
- Business Quant data shows PRCT's Income from Continuing Operations at 31638000.0 in Q1 2026, 31872000.0 in Q4 2025, and 60749000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.51 Bn | 194.91 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.96 Bn | 126.48 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.18 Bn | 110.96 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.28 Bn | 73.74 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.75 Bn | 48.50 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.67 Bn | 32.73 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.23 Bn | 32.12 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.14 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.30 Bn | 22.82 Bn | 684.20 Mn | 201.00 Mn |
| 10 | PROCEPT BioRobotics | 1.25 Bn | 970.12 Mn | 62.38 Mn | -26.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -26.86 Mn |
| Mar 31, 2026 | -31.64 Mn |
| Dec 31, 2025 | -31.87 Mn |
| Sep 30, 2025 | -60.75 Mn |
| Jun 30, 2025 | -60.82 Mn |
| Mar 31, 2025 | -24.74 Mn |
| Dec 31, 2024 | -20.85 Mn |
| Sep 30, 2024 | -35.05 Mn |
| Jun 30, 2024 | -31.64 Mn |
| Mar 31, 2024 | -41.54 Mn |
| Dec 31, 2023 | -32.12 Mn |
| Sep 30, 2023 | -30.04 Mn |
| Jun 30, 2023 | -44.05 Mn |
| Mar 31, 2023 | -77.96 Mn |
| Dec 31, 2022 | -23.97 Mn |
| Sep 30, 2022 | -39.54 Mn |
| Jun 30, 2022 | -19.32 Mn |
| Mar 31, 2022 | -19.64 Mn |
| Dec 31, 2021 | -18.02 Mn |
| Sep 30, 2021 | -17.94 Mn |